8-K filed Sep 9, 2026 at 06:31 ET
Chemours filed an 8-K furnishing its September 2026 investor presentation, which recaps Q2 2026 results, the Pathway to Thrive strategy, and growth initiatives in AI infrastructure and data center cooling. The presentation reiterates known financial data (Net Sales $1,591M, Adj. EBITDA $247M) and forward-looking targets (net leverage below 3x, >$250M cost savings), but does not introduce material new information or guidance changes.